Navigation Links
Phytomedics Inc. Appoints Dr. Laurie Smaldone Alsup, MD., as President and Chief Executive Officer

JAMESBURG, N.J., April 15 /PRNewswire/ -- Phytomedics Inc., an innovative clinical stage biopharmaceutical company pioneering the development novel multi-mechanism therapeutics from natural sources, today announced that Dr. Laurie Smaldone Alsup, MD., has joined the company as its President and Chief Executive Officer. She succeeds Dr. Bertold Fridlender who is announcing his retirement, but who will remain on the company's board of directors.

"Dr. Smaldone Alsup brings to Phytomedics an extensive background in drug development as well as executive leadership in various roles," said Aki von Roy, chairman of Phytomedics board of directors. "Her distinguished career and accomplishments in the pharmaceutical industry will be an invaluable asset in moving Phytomedics products forward into the market place."

Prior to joining Phytomedics, Dr. Smaldone Alsup served a distinguished 16-year career at Bristol-Myers Squibb in various executive and R&D roles. Most recently she was VP of Corporate Strategy and Issues Management involved in developing a corporate-wide business risk management capability and process. Previously, Dr. Smaldone Alsup headed Global Regulatory Sciences for the Pharmaceutical Research Institute, overseeing the regulatory approval process and pharmacovigilance for all products. She initially joined the company as a director of clinical research oncology and held clinical development positions of increasing responsibility including oversight for HIV/AIDS and infectious diseases. In these positions, Dr. Smaldone Alsup has played a role in the development of new medications to treat chronic, debilitating, and fatal diseases. She holds an M.D. degree from Yale University School of Medicine, New Haven, CT.

Dr. Smaldone Alsup has conducted clinical research throughout her career, which has been published in medical journals and presented to her peers at leading medical symposia and congresses. Dr. Smaldone Alsup serves on the board of the Hi-Tops Teen Reproductive Health Organization and McCarter Theater in Princeton, NJ. She is also a member of The Conference Board's Strategic Risk Management Council as well as a member of the Council's Executive Committee.

"The position of President and Chief Executive Officer of Phytomedics is an outstanding opportunity to lead a company with a promising future," said Smaldone Alsup. "I look forward to advancing our strong pipeline of products through the clinic and into the market to deliver innovative and efficacious products to patients."

Commenting of Dr. Fridlender's retirement, "Dr. Fridlender has done a terrific job in transitioning Phytomedics from a virtual company, to one with a broad product pipeline, multiple technologies, and a potential blockbuster product already in late stage development," said von Roy. "We now look forward to a new era in our company's development as we transition towards our commercialization strategy."

About Phytomedics, Inc.

Phytomedics Inc. ( is focused on the discovery, development, manufacture, and commercialization novel, multi-component and multi-functional drugs from natural sources. The Company has produced a pipeline of lead compounds, several of which are in clinical development, some as far as Phase IIb. Founded by Professor Ilya Raskin, Ph.D., Phytomedics Inc. conducts most of its R&D at the Biotech Center of Rutgers University.

SOURCE Phytomedics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Phytomedics Inc. to Present at Wachovia 2008 Healthcare Conference
2. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
3. Codexis Appoints Singapore Laboratories Managing Director
4. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
5. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
8. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
9. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
10. NeurogesX Appoints New Director to the Board
11. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
Post Your Comments:
(Date:11/25/2015)... ... 25, 2015 , ... A long-standing partnership between the Academy ... been formalized with the signing of a Memorandum of Understanding. , AMA Executive ... Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA Headquarters ...
(Date:11/24/2015)... ... 24, 2015 , ... The United States Golf Association (USGA) today announced Dr. ... Award. Presented annually since 1961, the USGA Green Section Award recognizes an individual’s distinguished ... , Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology in ...
(Date:11/24/2015)... ... November 24, 2015 , ... International Society for ... of the premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. The conference ... ISPE hosted the largest number of attendees in more than a decade. ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... The Academy ... Special Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the ... last few years. Many AMA members have embraced this type of racing and several ...
Breaking Biology Technology:
(Date:11/19/2015)... 2015  Based on its in-depth analysis of the ... with the 2015 Global Frost & Sullivan Award for ... presents this award to the company that has developed ... of the market it serves. The award recognizes the ... on customer base demands, the overall impact it has ...
(Date:11/18/2015)... New York , November 18, 2015 ... Market Research has published a new market report titled ... Growth, Trends, and Forecast, 2015 - 2021. According to the ... in 2014 and is anticipated to reach US$29.1 bn ... to 2021. North America ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
Breaking Biology News(10 mins):